Hearing loss trials in United States
113 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEvaluating a Noise Reduction Algorithm With Cochlear Implant Users
- Where
- New York
- Age
- 12 years and over
- People
- 60
- Run by
- NYU Langone Health
See details and how to joinNCT05805384 - No phaseEnrolling by invitationAutomated Text Message Reminders to Promote Hearing Aid Adoption
- Where
- Stanford
- Age
- 18 years and over
- People
- 190
- Run by
- Stanford University
See details and how to joinNCT07170423 - No phaseEnrolling by invitationA Multilevel Intervention to Prevent Noise Exposure in Farmworkers
- Where
- San Diego
- Age
- 18 years and over
- People
- 200
- Run by
- San Diego State University
See details and how to joinNCT07554378 - No phaseTaking peopleNatural History of Autosomal Dominant Hearing Loss
- Where
- Bethesda
- Age
- 3 years to 99 years
- People
- 1,100
- Run by
- National Institute on Deafness and Other Communication Disorders (NIDCD)
See details and how to joinNCT04501081 - No phaseTaking peopleHEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
- Where
- Baltimore
- Age
- 60 years to 100 years
- People
- 300
- Run by
- Johns Hopkins University
See details and how to joinNCT06930560 - No phaseTaking peopleAudiological Rehabilitation of Children With Unilateral Hearing Loss
- Where
- Chapell Hill, Iowa City, Omaha
- Age
- 6 years to 16 years
- People
- 160
- Run by
- Father Flanagan's Boys' Home
See details and how to joinNCT07911852 - Phase 1/2Taking peopleAnti-VEGF Gene Therapy Trial for Vestibular Schwannoma
- Where
- Baltimore, Dallas, Nashville, Rochester
- Age
- 18 years and over
- People
- 27
- Run by
- Eli Lilly and Company
See details and how to joinNCT06517888 - Phase 2/3Enrolling by invitationLong Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy
- Where
- Boston, Iowa City, Philadelphia
- People
- 30 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06696456 · EU 2024-512584-31-00 - No phaseEnrolling by invitationLong Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy
- Where
- Dallas
- Age
- 18 years and over
- People
- 100
- Run by
- Eli Lilly and Company
See details and how to joinNCT07503613 - No phaseTaking peopleBarriers and Facilitators to OTC Hearing Aids Success
- Where
- Iowa City, Nashville
- Age
- 18 years to 89 years
- People
- 360
- Run by
- Yu-Hsiang Wu
See details and how to joinNCT06499805 - No phaseTaking peopleCollection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Disorders.
- Where
- Bethesda
- Age
- 2 years to 99 years
- People
- 600
- Run by
- National Institute on Deafness and Other Communication Disorders (NIDCD)
See details and how to joinNCT05670496 - No phaseTaking peopleInvestigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants
- Where
- New York
- Age
- 2 years to 90 years
- People
- 200
- Run by
- NYU Langone Health
See details and how to joinNCT05810220 - No phaseTaking peopleRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
- Where
- Sioux Falls
- People
- 20,000
- Run by
- Sanford Health
See details and how to joinNCT01793168 - No phaseTaking peopleFall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device
- Where
- Palo Alto
- Age
- 55 years and over
- People
- 350
- Run by
- Stanford University
See details and how to joinNCT05365646 - No phaseTaking peopleAssessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter Hearing Aids in Rural Alabama and Mississippi Pharmacies
- Where
- Tuscaloosa
- Age
- 18 years and over
- People
- 144
- Run by
- University of Alabama, Tuscaloosa
See details and how to joinNCT06864273 - Phase 3Taking peopleKHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
- Where
- Boston, Cleveland, Houston
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Khondrion BV
See details and how to joinNCT06451757 - No phaseTaking peopleImproving Cochlear Implant Outcomes Through Modeling and Programming Strategies Based on Human Inner Ear Pathology
- Where
- Boston
- Age
- 18 years to 80 years
- People
- 45
- Run by
- Massachusetts Eye and Ear Infirmary
See details and how to joinNCT07683689 - No phaseTaking peopleHearing Impairment, Strategies and Outcomes in VA Emergency Departments
- Where
- Aurora, Dallas, Durham, New York, Syracuse, The Bronx
- Age
- 60 years and over
- People
- 1,050
- Run by
- VA Office of Research and Development
See details and how to joinNCT05028972 - No phaseTaking peopleNIDCD Otolaryngology Clinical Protocol Biospecimen Bank
- Where
- Bethesda
- Age
- 3 years to 99 years
- People
- 1,000
- Run by
- National Institute on Deafness and Other Communication Disorders (NIDCD)
See details and how to joinNCT06303180 - Phase 1/2Not yet taking people in United StatesA Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
- Where
- Washington D.C.
- Age
- 18 years to 65 years
- People
- 24
- Run by
- George Washington University
See details and how to joinNCT06792500 - Phase 2Taking peoplePrevention of Ototoxicity in NTM Patients Treated With IV Amikacin
- Where
- Baltimore, Charleston, Denver, Manhasset, Portland, Rochester, San Francisco, Tyler
- Age
- 18 years to 80 years
- People
- 105
- Run by
- Kevin Winthrop
See details and how to joinNCT05730283 - Phase 3Taking peopleGene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
- Where
- Boston, Cincinnati, Iowa City, Nashville, Philadelphia, San Francisco
- People
- 48 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05821959 · EU 2026-525943-33-00 - No phaseTaking peopleImproving Spatial Perception and Speech Understanding in Multitalker Mixtures
- Where
- Boston
- Age
- 18 years to 80 years
- People
- 220
- Run by
- Boston University Charles River Campus
See details and how to joinNCT05260307 - No phaseTaking peopleEvaluation of Flexible Conductive Hearing Aids
- Where
- Winston-Salem
- Age
- 6 months to 80 years
- People
- 200
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07222202 - No phaseNot yet taking people in United StatesThe Hear Clear Study
- Where
- Columbus, Durham
- Age
- 18 years and over
- People
- 125
- Run by
- Duke University
See details and how to joinNCT07824115